174 related articles for article (PubMed ID: 19837793)
21. Contribution of visceral adiposity and insulin resistance to metabolic risk factors in Japanese men.
Oka R; Kobayashi J; Inazu A; Yagi K; Miyamoto S; Sakurai M; Nakamura K; Miura K; Nakagawa H; Yamagishi M
Metabolism; 2010 May; 59(5):748-54. PubMed ID: 19926101
[TBL] [Abstract][Full Text] [Related]
22. Visceral adipose tissue and the risk of colorectal adenomas: a meta-analysis of observational studies.
Hu H; Cai Y; Huang J; Zhang J; Deng Y
Eur J Cancer Prev; 2015 Nov; 24(6):462-9. PubMed ID: 25494291
[TBL] [Abstract][Full Text] [Related]
23. Insulin resistance, apoptosis, and colorectal adenoma risk.
Keku TO; Lund PK; Galanko J; Simmons JG; Woosley JT; Sandler RS
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2076-81. PubMed ID: 16172212
[TBL] [Abstract][Full Text] [Related]
24. Associations of smoking cessation with visceral fat area and prevalence of metabolic syndrome in men: the Hitachi health study.
Matsushita Y; Nakagawa T; Yamamoto S; Takahashi Y; Noda M; Mizoue T
Obesity (Silver Spring); 2011 Mar; 19(3):647-51. PubMed ID: 20966912
[TBL] [Abstract][Full Text] [Related]
25. Visceral Adipose Tissue Volume and the Occurrence of Colorectal Adenoma in Follow-up Colonoscopy for Screening and Surveillance.
Kim B; Kim BC; Nam SY; Nam JH; Ryu KH; Park BJ; Sohn DK; Hong CW; Han KS; Kim HB
Nutr Cancer; 2017 Jul; 69(5):739-745. PubMed ID: 28569608
[TBL] [Abstract][Full Text] [Related]
26. Perturbed adipose tissue hydrogen peroxide metabolism in centrally obese men: Association with insulin resistance.
Akl MG; Fawzy E; Deif M; Farouk A; Elshorbagy AK
PLoS One; 2017; 12(5):e0177268. PubMed ID: 28545081
[TBL] [Abstract][Full Text] [Related]
27. Visceral Adiposity Index is a predictor of incident colorectal cancer: a population-based longitudinal study.
Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
BMJ Open Gastroenterol; 2020 Jun; 7(1):. PubMed ID: 32595114
[TBL] [Abstract][Full Text] [Related]
28. Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines.
Takei R; Inoue T; Sonoda N; Kohjima M; Okamoto M; Sakamoto R; Inoguchi T; Ogawa Y
PLoS One; 2019; 14(10):e0223302. PubMed ID: 31577826
[TBL] [Abstract][Full Text] [Related]
29. Adipose Y5R mRNA is higher in obese than non-obese humans and is correlated with obesity parameters.
Chatree S; Sitticharoon C; Maikaew P; Uawithya P; Chearskul S
Exp Biol Med (Maywood); 2018 May; 243(9):786-795. PubMed ID: 29763369
[TBL] [Abstract][Full Text] [Related]
30. Visceral abdominal obesity is associated with an increased risk of irritable bowel syndrome.
Lee CG; Lee JK; Kang YS; Shin S; Kim JH; Lim YJ; Koh MS; Lee JH; Kang HW
Am J Gastroenterol; 2015 Feb; 110(2):310-9. PubMed ID: 25583325
[TBL] [Abstract][Full Text] [Related]
31. Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes.
Nam SY; Kim BC; Han KS; Ryu KH; Park BJ; Kim HB; Nam BH
Clin Gastroenterol Hepatol; 2010 May; 8(5):443-50.e1-2. PubMed ID: 20144736
[TBL] [Abstract][Full Text] [Related]
32. [Relation between insulin resistance and amount of visceral adipose tissue].
Bajzová M; Kováciková M; Vítková M; Polák J; Klimcáková E; Srp A; Vedral T; Mikulásek L; Srámková SP; Stich V; Hejnová J
Cas Lek Cesk; 2008; 147(7):376-80. PubMed ID: 18678096
[TBL] [Abstract][Full Text] [Related]
33. Visceral Abdominal Obesity Measured by Computed Tomography is Associated With Increased Risk of Colonic Diverticulosis.
Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Aoki T; Sekine K; Okubo H; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Noda M; Itoh T; Mizokami M; Uemura N
J Clin Gastroenterol; 2015; 49(10):816-22. PubMed ID: 25412157
[TBL] [Abstract][Full Text] [Related]
34. Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer.
Park JW; Chang SY; Lim JS; Park SJ; Park JJ; Cheon JH; Kim WH; Kim TI
Gut Liver; 2022 Jan; 16(1):53-61. PubMed ID: 34312323
[TBL] [Abstract][Full Text] [Related]
35. Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle-aged Japanese men.
Hirayama S; Hori A; Isshiki M; Hirayama A; Ueno T; Tamura Y; Kaga H; Watada H; Kawamori R; Miida T
J Clin Lipidol; 2020; 14(4):522-530. PubMed ID: 32654995
[TBL] [Abstract][Full Text] [Related]
36. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
[TBL] [Abstract][Full Text] [Related]
37. The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome.
Lord J; Thomas R; Fox B; Acharya U; Wilkin T
BJOG; 2006 Oct; 113(10):1203-9. PubMed ID: 16753044
[TBL] [Abstract][Full Text] [Related]
38. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.
Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P
Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190
[TBL] [Abstract][Full Text] [Related]
39. A Common Variant of NGEF Is Associated with Abdominal Visceral Fat in Korean Men.
Kim HJ; Park JH; Lee S; Son HY; Hwang J; Chae J; Yun JM; Kwon H; Kim JI; Cho B
PLoS One; 2015; 10(9):e0137564. PubMed ID: 26340433
[TBL] [Abstract][Full Text] [Related]
40. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.
Preis SR; Massaro JM; Robins SJ; Hoffmann U; Vasan RS; Irlbeck T; Meigs JB; Sutherland P; D'Agostino RB; O'Donnell CJ; Fox CS
Obesity (Silver Spring); 2010 Nov; 18(11):2191-8. PubMed ID: 20339361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
